Thalamic deep brain stimulation for Tourette Syndrome: A naturalistic trial with brief randomized, double-blinded sham-controlled periods
There is still a lack of controlled studies to prove efficacy of thalamic deep brain stimulation for Tourette's Syndrome. In this controlled trial, we investigated the course of tic severity, comorbidities and quality of life during thalamic stimulation and whether changes in tic severity can b...
Gespeichert in:
Veröffentlicht in: | Brain stimulation 2021-09, Vol.14 (5), p.1059-1067 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | There is still a lack of controlled studies to prove efficacy of thalamic deep brain stimulation for Tourette's Syndrome.
In this controlled trial, we investigated the course of tic severity, comorbidities and quality of life during thalamic stimulation and whether changes in tic severity can be assigned to ongoing compared to sham stimulation.
We included eight adult patients with medically refractory Tourette's syndrome. Bilateral electrodes were implanted in the centromedian-parafascicular-complex and the nucleus ventro-oralis internus. Tic severity, quality of life and comorbidities were assessed before surgery as well as six and twelve months after. Short randomized, double-blinded sham-controlled crossover sequences with either active or sham stimulation were implemented at both six- and twelve-months’ assessments. The primary outcome measurement was the difference in the Yale Global Tic Severity Scale tic score between active and sham stimulation. Adverse events were systematically surveyed for all patients to evaluate safety.
Active stimulation resulted in significantly higher tic reductions than sham stimulation (F = 79.5; p = 0.001). Overall quality of life and comorbidities improved significantly in the open-label-phase. Over the course of the trial two severe adverse events occurred that were resolved without sequelae.
Our results provide evidence that thalamic stimulation is effective in improving tic severity and overall quality of life. Crucially, the reduction of tic severity was primarily driven by active stimulation. Further research may focus on improving stimulation protocols and refining patient selection to improve efficacy and safety of deep brain stimulation for Tourette's Syndrome.
•There is insufficient data from controlled trials to determine efficacy of thalamic DBS for Tourette Syndrome.•In this trial of n = 8, tic severity, quality of life and comorbidities significantly improved with continuous DBS.•Double-blinded discontinuation of stimulation resulted in a significant relapse of tic severity.•Our study adds novel evidence that thalamic DBS is a safe and effective treatment for severe Tourette Syndrome. |
---|---|
ISSN: | 1935-861X 1876-4754 |
DOI: | 10.1016/j.brs.2021.07.003 |